4.6 Article

Putaminal Recombinant Glucocerebrosidase Delivery with Magnetic Resonance-Guided Focused Ultrasound in Parkinson's Disease: A Phase I Study

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Striatal Blood-Brain Barrier Opening in Parkinson's Disease Dementia: A Pilot Exploratory Study

Jose A. Pineda-Pardo et al.

Summary: This study aims to investigate the safety and feasibility of opening the blood-brain barrier in the striatum of Parkinson's disease patients using focused ultrasound. The results of the study suggest that this technique is feasible and safe, and may potentially be an effective tool for delivering therapeutic molecules in Parkinson's disease.

MOVEMENT DISORDERS (2022)

Article Neurosciences

Fibroblasts from idiopathic Parkinson's disease exhibit deficiency of lysosomal glucocerebrosidase activity associated with reduced levels of the trafficking receptor LIMP2

Ria Thomas et al.

Summary: This study demonstrates that fibroblasts from idiopathic PD patients show reduced lysosomal GCase activity due to impaired GBA protein trafficking to lysosomes, while genetic PD cells with GBA N370S mutation exhibit a different mechanism for decreased GCase activity.

MOLECULAR BRAIN (2021)

Article Oncology

MR-guided focused ultrasound liquid biopsy enriches circulating biomarkers in patients with brain tumors

Ying Meng et al.

Summary: This study demonstrates that MRgFUS has the potential to enrich circulating brain-derived biomarkers, showing promising applications for liquid biopsy in the brain.

NEURO-ONCOLOGY (2021)

Article Cell Biology

MR-guided focused ultrasound enhances delivery of trastuzumab to Her2-positive brain metastases

Ying Meng et al.

Summary: This study provides evidence of enhanced brain penetration of trastuzumab using MRgFUS in patients with Her2-positive breast cancer, demonstrating the potential of this technology for a broad range of CNS diseases.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Blood-brain barrier opening with focused ultrasound in Parkinson's disease dementia

Carmen Gasca-Salas et al.

Summary: MRgFUS-BBB opening in PDD is safe, reversible, and can be performed repeatedly. This study provides encouragement for the concept of BBB opening for drug delivery to treat dementia in PD and other neurodegenerative disorders.

NATURE COMMUNICATIONS (2021)

Review Biochemistry & Molecular Biology

Gene Therapy for Lysosomal Storage Disorders: Ongoing Studies and Clinical Development

Giulia Massaro et al.

Summary: This study provides a comprehensive overview of the current state of gene therapy in lysosomal diseases, including viral gene delivery vectors, relevant pre-clinical studies, and ongoing clinical trials in recent years.

BIOMOLECULES (2021)

Article Radiology, Nuclear Medicine & Medical Imaging

Regional Differences in Blood-Brain Barrier Permeability in Cognitively Normal Elderly Subjects: A Dynamic Contrast-Enhanced MRI-Based Study

Il Heon Ha et al.

Summary: This study found regional differences in BBB permeability in cognitively normal elderly adults, which were not related to age, cognitive score, vascular risk burden, vascular risk factors on imaging, or medial temporal lobar atrophy.

KOREAN JOURNAL OF RADIOLOGY (2021)

Article Biochemistry & Molecular Biology

Glucocerebrosidase deficiency promotes release of α-synuclein fibrils from cultured neurons

Matthew E. Gegg et al.

HUMAN MOLECULAR GENETICS (2020)

Review Clinical Neurology

Data-driven evolution of neurosurgical gene therapy delivery in Parkinson's disease

R. Mark Richardson et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Article Clinical Neurology

Parkinson's disease: etiopathogenesis and treatment

Joseph Jankovic et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)

Article Multidisciplinary Sciences

Blood-brain barrier opening in Alzheimer's disease using MR-guided focused ultrasound

Nir Lipsman et al.

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

Reduced glucocerebrosidase activity in monocytes from patients with Parkinson's disease

Farzaneh Atashrazm et al.

SCIENTIFIC REPORTS (2018)

Article Clinical Neurology

Cerebrospinal Fluid β-Glucocerebrosidase Activity Is Reduced in Parkinson's Disease Patients

Lucilla Parnetti et al.

MOVEMENT DISORDERS (2017)

Article Cell Biology

Long-Term Health of Dopaminergic Neuron Transplants in Parkinson's Disease Patients

Penelope J. Hallett et al.

CELL REPORTS (2014)

Article Multidisciplinary Sciences

CNS expression of glucocerebrosidase corrects α-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy

S. Pablo Sardi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article

The Expanding Role of Genetics in the Lewy Body Diseases

James B. Leverenz et al.

ARCHIVES OF NEUROLOGY (2009)

Article Clinical Neurology

Metabolic Networks for Assessment of Therapy and Diagnosis in Parkinson's Disease

Shigeki Hirano et al.

MOVEMENT DISORDERS (2009)

Article Clinical Neurology

Real-time image-guided direct convective perfusion of intrinsic brainstem lesions

Russell R. Lonser et al.

JOURNAL OF NEUROSURGERY (2007)

Article Clinical Neurology

Changes in network activity with the progression of Parkinson's disease

Chaorui Huang et al.

BRAIN (2007)

Review Clinical Neurology

Epidemiology of Parkinson's disease

Lonneke M. L. de Lau et al.

LANCET NEUROLOGY (2006)

Article Medicine, General & Internal

Transplantation of embryonic dopamine neurons for severe Parkinson's disease.

CR Freed et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)